Erik Fadlovich

Early-stage and emerging pharma companies must design supply chains that can support rapid growth, late-stage clinical milestones, and the transition to commercial production—all while operating with lean teams and limited infrastructure. This panel brings together biotech supply chain leaders to discuss how they build foundational processes, choose the right partners, manage risk with small volumes, and establish the capabilities needed for future scale.

• Establish essential supply chain capabilities early, including forecasting, quality systems, material planning, logistics, and supplier management
• Leverage partners strategically to close capability gaps without overbuilding internal teams too soon
• Prepare for scale-up by designing flexible processes and networks that can grow with portfolio and demand complexity